MedTrace Logo

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

NCT01156844 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 191

Last updated 2011-08-17

Study results available
· View outcomes & findings →

Summary

This study assessed the bronchodilator efficacy of three different regimens of indacaterol in patients with asthma

Conditions

  • Persistent Asthma

Interventions

DRUG

Indacaterol

Indacaterol inhaled via Concept1, a single dose dry powder inhaler (SDDPI) for 16 days. Dosage and frequency varied according to randomization scheme.

DRUG

Placebo to Indacaterol

Placebo inhaled via Concept1, a SDDPI. Frequency varied according to randomization scheme.

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-07-31

Countries

  • United States
  • France
  • Germany
  • Jordan
  • Netherlands
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156844 on ClinicalTrials.gov